Chlorphenoxamine - CAS 77-38-3
Catalog number: 77-38-3
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C18H22ClNO
Molecular Weight:
303.84
COA:
Inquire
Targets:
Histamine Receptor
Description:
Chlorphenoxamine is an analog of diphenhydramine. It has antimuscarinic and antihistaminic properties. It has been used as an antipruritic and antiparkinsonian agent.
Purity:
>98%
Appearance:
Solid powder
Synonyms:
2-(1-(p-Chlorophenyl)-1-phenylethoxy)-N,N-dimethylethylamine;2-[1-(4-Chlorophenyl)-1-phenylethoxy]-N,N-dimethylethanamine;beta-Dimethylamino-aethyl-(p-chlor-alpha-methylbenzhydryl)-aether;Ethylamine, 2-[1-(p-chlorophenyl)-1-phenylethoxy]-N,N-dimethyl-;p-Chlor-alpha-methyl-diphenhydramin;N-(2-(1-p-chlorophenyl-1-phenylethoxy)ethyl)dimethylamine;1-(4-Chlorophenyl)-1-[2-(dimethylamino)ethoxy]-1-phenylethane;Contristamine; Systral
Solubility:
DMSO: ≥ 48 mg/mL
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Chlorphenoxamine has been used as an antipruritic and antiparkinsonian agent.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
Boiling Point:
383.7°C at 760 mmHg
Melting Point:
152.5 °C
Density:
1.093±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
KKHPNPMTPORSQE-UHFFFAOYSA-N
InChI:
InChI=1S/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3
Canonical SMILES:
CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCN(C)C
Current Developer:
It has been approved the listing.
1.Simultaneous determination of caffeine, 8-chlorotheophylline, and chlorphenoxamine hydrochloride in ternary mixtures by ratio-spectra zero-crossing first-derivative spectrophotometric and chemometric methods.
Kelani KM1. J AOAC Int. 2005 Jul-Aug;88(4):1126-34.
A ratio-spectra zero-crossing first-derivative spectrophotometric method and 2 chemometric methods have been used for the simultaneous determination of ternary mixtures of caffeine (A), 8-chlorotheophylline (B), and chlorphenoxamine hydrochloride (C) in bulk powder and dosage forms. In the ratio-spectra zero-crossing first-derivative spectrophotometric technique (1DD), calibration curves were linear in the range of 4-20 microg/mL for A, B, and C (r = 0.9992, 0.9994, and 0.9976, respectively). The measurements were carried out at 212, 209.2, and 231.4 nm for A, B, and C, respectively. The detection limits for A, B, and C were calculated to be 0.24, 0.34, and 0.13 microg/mL, and the percentage recoveries were 99.1 +/- 0.89, 100.1 +/- 0.95, and 100.1 +/- 1.0, respectively. Two chemometric methods, namely, the partial least-squares (PLS) model and the principal component regression (PCR) model, were also used for the simultaneous determination of the 3 drugs in the ternary mixture.
2.[Significance of chromatographic methods coupled with mass spectrometry for identification of drugs for medico-legal purposes exemplified by chlorphenoxamine].
Kłys M1, Rojek S, Masełko J. Arch Med Sadowej Kryminol. 2003 Apr-Jun;53(2):137-49.
This work presented the death of the 17-year old women M.F. The direct cause of death was violent strangulation. Toxicological investigation made possible a wider explanation of the case, since M.F. was under influence of associative action of diphenhydramine and ethanol which could not avoid having an influence on the tragic events accompanying the death. Besides a comprehensive interpretation of the toxicological results in medico--legal aspect large methodic documentation has been presented which proves the usefulness of chromatographic methods coupled with spectrometry for identification of xenobiotics found.
3.Simultaneous spectrophotometric determination of chlorphenoxamine hydrochloride and caffeine in a pharmaceutical preparation using first derivative of the ratio spectra and chemometric methods.
Dinç E1, Palabiyik IM, Ustündağ O, Yurtsever F, Onur F. J Pharm Biomed Anal. 2002 May 15;28(3-4):591-600.
Three new methods are described for the simultaneous determination of chlorphenoxamine hydrochloride (CP) and caffeine (CAF) in their combination. In the first method, ratio spectra derivative spectrophotometry, analytical signals were measured at the wavelengths corresponding to either maxima and minima for both drugs in the first derivative spectra of the ratio spectra obtained by using each other spectra as divisor in their solution in 0.1 M HCl. In the other two methods, chemometric techniques, classical least-squares (CLS) and inverse least-squares (ILS), the concentration data matrix were prepared by using the synthetic mixtures containing these drugs in 0.1 M HCl. The absorbance data matrix corresponding to the concentration data matrix was obtained by the measurements of absorbances in the range 225-285 nm in the intervals with Deltalambda = 5 nm at 13 wavelengths in their zero-order spectra, then, calibration or regression was obtained by using the absorbance data matrix and concentration data matrix for the prediction of the unknown concentrations of CP and CAF in their mixture.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products


CAS 1905481-36-8 KDM5A-IN-1

KDM5A-IN-1
(CAS: 1905481-36-8)

KDM5A-IN-1, a pyrrolidine amide compound, is an inhibitor histone demethylases.

CAS 59-33-6 Pyrilamine maleate salt

Pyrilamine maleate salt
(CAS: 59-33-6)

Pyrilamine maleate salt is a first generation antihistamine and binds with high affinity to G(q/11) protein. It is commonly utilized as a radioligand binding as...

CAS 1039399-17-1 PF-03654746 Tosylate

PF-03654746 Tosylate
(CAS: 1039399-17-1)

PF-03654746 Tosylate is a histamine H3 receptor antagonist undergoing a clinical trial for attention-deficit hyperactivity disorder (ADHD) therapy.

CAS 152241-24-2 GT 2016

GT 2016
(CAS: 152241-24-2)

GT 2016 is a high affinity and brain-penetrant histamine H3 receptor antagonist (Ki = 43.8 nM). It displays selectivity against H1 and H2 receptors (IC50 >10 μM...

CAS 460748-71-4 ABT 239 tartrate

ABT 239 tartrate
(CAS: 460748-71-4)

ABT 239 tartrate is a potent and selective histamine H3 receptor antagonist or inverse agonist.

CAS 980-71-2 Brompheniramine hydrogen maleate

Brompheniramine hydrogen maleate
(CAS: 980-71-2)

Brompheniramine hydrogen maleate is a histamine H1 receptors antagonist.

CAS 75614-93-6 (S)-(+)-α-Methylhistamine dihydrobromide

(S)-(+)-α-Methylhistamine dihydrobromide
(CAS: 75614-93-6)

(S)-(+)-α-Methylhistamine dihydrobromide is the less active enantiomer of histamine H3 receptor agonist R-(-)-α-methylhistamine, with 120-fold less potent than ...

CAS 1038917-11-1 OUP16

OUP16
(CAS: 1038917-11-1)

OUP16 is a potent and selective histamine H4 receptor(hH4R) agonist with 40-fold selectivity over the hH3R and superior to its (2S,5S)-configured optical antipo...

Chemical Structure

CAS 77-38-3 Chlorphenoxamine

Quick Inquiry

Verification code

Featured Items